About Dr. Hirschbein

Associate Chairman
Krieger Eye Institute
Ophthalmic Plastic and Reconstructive Surgery
Fellow of the American Board of Ophthalmology

Current Position

Associate Chairman
Krieger Eye Institute
Oculoplastic, Aesthetic, and Reconstructive Surgery (1999-present)
Co-Director, Krieger Eye Institute ASOPRS Oculoplastic Fellowship (2004-present)

Board Certification
American Board of Ophthalmology, 1999

Secretary, Maryland Society of Eye Physicians and Surgeons. (2003-present)
Treasurer, Maryland Society of Eye Physicians and Surgeons. (2001-2003)
National Cyberknife Protocol Steering Committee (2003 – present)
Institutional Review Board, Sinai Hospital of Baltimore (2000-2002)

1998-1999 Fellowship in Oculoplastic Surgery (ASOPRS)
Albany Eye Physicians and Surgeons and
Albany Medical Center

1995 - 1998 Residency in Ophthalmology
Sinai Hospital of Baltimore
Department of Ophthalmology

1994-1995 Internship in Internal Medicine
Sinai Hospital of Baltimore
Department of Internal Medicine

1990-1994 Doctor of Medicine
Hahnemann University School of Medicine
Philadelphia, Pennsylvania

1986-1990 Bachelor of Science, Biology with General Honors
University of Maryland
College Park, Maryland

American Academy of Ophthalmology
American Society of Ophthal Plastic and Reconstructive Surgery
American College of Surgeons
American Academy of Cosmetic Surgery
American Medical Association
Pan-American Association of Ophthalmology
Maryland Society of Eye Physicians and Surgeons
Cyberknife Society

Citation in General Honors
Phi Sigma National Biological Honors Society
Golden Key National Honors Society

Hospital Affiliations
Sinai Hospital of Baltimore (1999 - present)
Clinical Instructor, Wilmer Eye Institute, Johns Hopkins University
Mercy Medical Center
Northwest Hospital
York Hospital
Lancaster General Hospital

Current Research Interests
Optic nerve dose tolerances to hypofractionated stereotactic radiosurgery with the cyberknife system.
Eyelid retraction repair using a new porcine dermal implant.
Punctoplasty with adjuvant topical mitomycin-c.